Kalaris Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 05/15/2026 | 12.95 M | $74.71 M | 0.00% | 56.54% |
| RTW INVESTMENTS, LP | 05/15/2026 | 1.30 M | $7.50 M | 0.00% | 5.68% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2026 | 700.00 K | $4.04 M | 0.00% | 3.06% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 572.69 K | $3.27 M | 41.91% | 2.50% |
| SIREN, L.L.C. | 05/14/2026 | 435.80 K | $2.51 M | 0.00% | 1.90% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 360.00 K | $2.08 M | 0.00% | 1.57% |
| PROPEL BIO MANAGEMENT, LLC | 05/14/2026 | 295.77 K | $1.72 M | 603.33% | 1.29% |
| 05/15/2026 | 255.35 K | $1.47 M | 100.00% | 1.11% | |
| 05/15/2026 | 135.59 K | $782.33 K | -3.09% | 0.59% | |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 118.89 K | $685.98 K | 34.43% | 0.52% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 110.50 K | $637.60 K | 222.14% | 0.48% |
| WOODLINE PARTNERS LP | 05/15/2026 | 100.00 K | $577.00 K | 0.00% | 0.44% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 100.00 K | $577.00 K | 0.00% | 0.44% |
| 04/24/2026 | 97.49 K | $562.54 K | 0.00% | 0.43% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 92.26 K | $532.35 K | 0.00% | 0.40% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 87.55 K | $505.34 K | 5.93% | 0.38% |
| SIMPLIFY ASSET MANAGEMENT INC. | 04/27/2026 | 87.43 K | $504.45 K | 335.52% | 0.38% |
| MARSHALL WACE, LLP | 05/15/2026 | 67.88 K | $391.66 K | -6.86% | 0.30% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 66.15 K | $381.69 K | -24.62% | 0.29% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 59.53 K | $343.51 K | 100.00% | 0.26% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 52.68 K | $303.99 K | 309.80% | 0.23% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 45.00 K | $259.65 K | -44.16% | 0.20% |
| BELPOINTE ASSET MANAGEMENT LLC | 04/28/2026 | 40.00 K | $230.80 K | 0.00% | 0.17% |
| FORTIS CAPITAL ADVISORS, LLC | 04/28/2026 | 40.00 K | $230.80 K | 0.00% | 0.17% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 39.77 K | $229.49 K | 56.79% | 0.17% |
| MORGAN STANLEY | 05/15/2026 | 38.34 K | $221.25 K | 37.20% | 0.17% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 36.72 K | $211.86 K | 100.00% | 0.16% |
| BLACKROCK, INC. | 05/13/2026 | 36.04 K | $207.97 K | -6.27% | 0.16% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 30.65 K | $176.85 K | 10.41% | 0.13% |
| STATE STREET CORP | 05/15/2026 | 26.51 K | $152.96 K | 4.33% | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 22.50 K | $129.83 K | 0.00% | 0.10% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 20.40 K | $117.71 K | 100.00% | 0.09% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2026 | 18.00 K | $103.86 K | 100.00% | 0.08% |
| RBF CAPITAL, LLC | 05/18/2026 | 17.39 K | $100.35 K | 0.00% | 0.08% |
| NORTHERN TRUST CORP | 05/14/2026 | 14.45 K | $83.37 K | 5.82% | 0.06% |
| INDEPENDENT ADVISOR ALLIANCE | 05/12/2026 | 14.23 K | $82.11 K | 100.00% | 0.06% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 13.66 K | $78.79 K | 34.41% | 0.06% |
| WEALTHTRUST ASSET MANAGEMENT, LLC | 05/06/2026 | 12.42 K | $71.64 K | 100.00% | 0.05% |
| HRT FINANCIAL LP | 05/14/2026 | 11.62 K | $67.00 K | 100.00% | 0.05% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 11.10 K | $64.06 K | 100.00% | 0.05% |
| JOHNSON FINANCIAL GROUP, INC. | 05/07/2026 | 10.00 K | $57.70 K | 0.00% | 0.04% |
| CITIGROUP INC | 05/11/2026 | 8.70 K | $50.22 K | 870,200.00% | 0.04% |
| FMR LLC | 05/15/2026 | 7.81 K | $45.04 K | 0.00% | 0.03% |
| UBS GROUP AG | 05/05/2026 | 6.18 K | $35.68 K | 129.80% | 0.03% |
| BARCLAYS PLC | 05/15/2026 | 5.28 K | $30.47 K | -12.94% | 0.02% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 05/15/2026 | 4.00 K | $23.08 K | 0.00% | 0.02% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/08/2026 | 2.22 K | $12.78 K | 100.00% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 725 | $4.18 K | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 652 | $3.76 K | 1,153.85% | 0.00% |
| STRENGTHENING FAMILIES & COMMUNITIES, LLC | 05/11/2026 | 268 | $1.55 K | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kalaris Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 63 institutional investors and hedge funds held shares of Kalaris Therapeutics Inc.. The most heavily invested institutionals were:
Samsara BioCapital, LLC: 12.95 M
RTW INVESTMENTS, LP: 1.3 M
Paradigm Biocapital Advisors LP: 700,000
Alyeska Investment Group, L.P.: 572,687
Siren, L.L.C.: 435,798
Ikarian Capital, LLC: 360,000
81.12% of Kalaris Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 18.38 M shares in the last 24 months. This purchase volume represents approximately $183.83 M in transactions.